UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
FORM 3
OMB APROVAL
OMB NUMBER: 3235-0104
Expires: December 31, 2001
Estimated average burden
hours per response........0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
1. Name and Address of Reporting Person*
Morgan Stanley Venture Capital III, Inc.(1)
- -----------------------------------------------------------------------------
(Last) (First) (Middle)
1221 Avenue of the Americas
- -----------------------------------------------------------------------------
(Street)
New York NY 10020
- -----------------------------------------------------------------------------
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/23/99
- -----------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person, if an entity (voluntary)
- -----------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
Cardiac Pathways Corporation (CPWY)
- -----------------------------------------------------------------------------
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
Director x 10% Owner
--- ---
Officer (give title below) Other (specify below)
--- ---
- ----------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
- -----------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
- ----
x Form filed by More than One Reporting Person
- ----
<PAGE>
Table I -- Non-Derivative Securities Beneficially Owned
<TABLE>
<CAPTION>
1. Title of Security 2. Amount of Securities 3. Ownership 4. Nature of Indirect
(Instr. 4) Beneficially Owned Form: Direct Beneficial Ownership
(Instr. 4) (D) or Indirect (Instr. 5)
(I)(Instr. 5)
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
</TABLE>
Explanation of Responses:
(1) Please see attached Joint Filer Information.
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see
Instruction 5(b)(v).
(Over)
SEC 1473 (7-97)
<PAGE>
FORM 3 (contniued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
1. Title of Derivative 2. Date Exercisable 3. Title and Amount of 4. Conver- 5. Owner- 6. Nature
Security (Instr. 4) and Expiration Securities Underlying sion or ship of In-
Date (Month/Day/Year) Derivative Security Exercise Form of direct
------------------------- (Instr. 4) Price of Deriv- Bene-
Date Expira- ------------------------- Derivative ative ficial
Exer- tion Title Amount Security Security: Owner-
cisable Date or Direct ship
Number (D) or (Instr.
of Indirect 5)
Shares (I)
(Instr.
5)
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Series B Convertible Preferred Stock Immed. N/A Common Stock 2,000,000 $1,000.00(2) I(3) Through
Partnerships
Series B Convertible Preferred Stock
Warrants(4) Immed. 5/31/04 Common Stock 20,000 $1,000.00(2) I(3) Through
Partnerships
</TABLE>
(2) The initial purchase price of each share of Series B Convertible Preferred
Stock and each Series B Convertible Preferred Stock Warrant was $1,000.00;
no additional payments must be made upon exercise or conversion.
(3) Except for Morgan Stanley Venture Partners III, L.P., Morgan Stanley
Venture Investors III, L.P. and The Morgan Stanley Venture Partners
Entrepreneur Fund, L.P. (collectively, the "Funds"), which hold the
securities directly.
(4) The Warrants are exercisable into Series B Convertible Preferred Stock,
which may be converted into Common Stock at anytime before their expiration
at the election of the Funds.
/s/ Stephanie Holmes August 4, 1999
- ------------------------------- ------------------------
**Signature of Reporting Person Date
By: Stephanie Holmes, authorized
signatory for Morgan Stanley Dean
Witter & Co. and Assistant Secretary
of Morgan Stanley Venture Capital III,
Inc. institutional managing member of
the Funds.
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
Page 2
SEC 1473 (7-97)
<PAGE>
Joint Filer Information
Each of the following joint filers has designated Morgan Stanley Venture
Capital III, Inc. ("MSVC III, Inc.") as the "Designated Filer" for purposes of
Item 1 of the attached Form 3:
(1) Morgan Stanley Dean Witter & Co. ("MSDW")
1585 Broadway
New York, New York 10036
(2) Morgan Stanley Venture Partners III, L.L.C. ("MSVP III, L.L.C.")
1221 Avenue of the Americas
New York, New York 10020
(3) Morgan Stanley Venture Partners III, L.P. ("MSVP III, L.P.")
1221 Avenue of the Americas
New York, New York 10020
(4) The Morgan Stanley Venture Partners Entrepreneur Fund, L.P.
("Entrepreneur Fund")
1221 Avenue of the Americas
New York, New York 10020
(5) Morgan Stanley Venture Investors III, L.P. ("MSVI")
1221 Avenue of the Americas
New York, New York 10020
Issuer & Ticker Symbol: Cardiac Pathways Corporation (CPWY)
Date of Event Requiring Statement: 7/23/99
Signature: /s/ Stephanie Holmes
------------------------------------
By: Stephanie Holmes, as authorized signatory for
MSDW and Assistant Secretary of MSVC III, Inc.,
institutional managing member of MSVP III, L.L.C.,
the General Partner of MSVP III, L.P., the Entrepreneur
Fund and MSVI
Page 3
SEC 1473 (7-97)
